-
AstraZeneca Appoints Dr. Susan Galbraith as Executive Vice President, Oncology Research & Development
americanpharmaceuticalreview
June 30, 2021
AstraZeneca has appointed Dr. Susan Galbraith to lead Oncology Research & Development. Her appointment follows the passing of José Baselga earlier this year.
-
Glenmark Appoints New Innovation Company CEO
contractpharma
March 07, 2019
Dr. Alessandro Riva will lead the new company, which will be a wholly-owned subsidiary of Glenmark and based in Paramus, NJ
-
Executive Moves: AbbVie
contractpharma
December 18, 2018
AbbVie has made changes to its Executive Leadership Team as part of an effort to streamline its organizational structure and support its growth strategy. The following will report to AbbVie chairman and chief executive officer Richard A. Gonzalez.
-
Alkermes, Biogen Submit NDA to FDA
contractpharma
December 18, 2018
Alkermes plc and Biogen Inc announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of mu
-
TFS International Appoints Dr Suzanne Pavon as Executive Vice President, Quality Assurance
b3cnewswire
July 04, 2018
TFS International is delighted to announce that Dr Suzanne Pavon has accepted the position of Executive Vice President, Quality Assurance. Dr Pavon is an entrepreneurial
-
PhRMA Announces New Chief Medical Officer, Executive Vice President
americanpharmaceuticalreview.
September 01, 2017
Moscicki received his medical degree from Northwestern University Medical School and is board certified in internal medicine, diagnostic and laboratory immunology, and allergy and immunology. Moscicki previously also served on staff at Massachusetts Gener
-
Novo Nordisk appoints new executive vice president
biospectrumasia
March 08, 2017
Jakob Riis will remain with Novo Nordisk in a transition period to help ensure a smooth handover